₹840.00
-10.35 (-1.22%)
As of 22 Sept 2026, Alembic Pharmaceuticals Ltd share price is ₹840.00. The stock opened at ₹840.00 and had closed at ₹850.35 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹635.30 and a high of ₹998.00. In terms of performance, Alembic Pharmaceuticals Ltd share price has increased by 31.58% over the past six months and has decreased by 9.56% over the last year.
APLLTD Stock Price Chart
Alembic Pharmaceuticals Ltd Overview
Market cap₹16,715 Crs
Volume2,208
Prev. Close₹850.35
Year range₹635.30 - ₹998.00
ISININE901L01018
About APLLTD
Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.
Alembic Pharmaceuticals Ltd Historical Performance
1 Month Return3.64%
6 Month Return25.60%
3 Year Return11.06%
3 Month Return8.90%
1 Year Return-10.49%
5 Year Return3.71%
Alembic Pharmaceuticals Ltd Fundamentals
ROCE(TTM)11.85%
P/E Ratio (TTM)22.78
P/B Ratio2.98
Debt to Equity0.21
ROE12.39%
EPS (TTM)40.14
Dividend Yield1.41%
Book Value285.67
Profit Margin11.23%
Operating Margin12.45%
Alembic Pharmaceuticals Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 6,707.28 | 6,080.51 | 5,905.38 | 5,152.55 | 5,086.55 |
| EBITDA | 1,051.62 | 962.14 | 1,029.84 | 667.88 | 959.95 |
| Net Profit | 640.42 | 503.12 | 666.48 | 346.73 | 543.55 |
| EPS | 32.58 | 25.60 | 33.91 | 17.64 | 27.65 |
Alembic Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 841.48 |
| Resistance 1 (R1) | 863.48 |
| Pivot Point | 854.62 |
Alembic Pharmaceuticals Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 29-Jul-2026 | 15-May-2026 | 29-Jul-2026 | Final | ₹12.00 |
| 29-Jul-2025 | 06-May-2025 | 29-Jul-2025 | Final | ₹11.00 |
| 15-Jul-2024 | 09-May-2024 | 15-Jul-2024 | Final | ₹11.00 |
| 28-Jul-2023 | 05-May-2023 | 28-Jul-2023 | Final | ₹8.00 |
| 17-Aug-2022 | 02-May-2022 | 18-Aug-2022 | Interim | ₹10.00 |
APLLTD Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| C R Amin | Executive Chairman |
| Rajkumar Baheti | Independent Director |
| Pranav Amin | Managing Director |
Alembic Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,864.00-0.26% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,421.00+0.11% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,949.00-0.42% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Alembic Pharmaceuticals Ltd today is ₹840.00 on NSE and ₹840.00 on BSE.
- The 52-week high of Alembic Pharmaceuticals Ltd is ₹998.00, while the 52-week low is ₹635.30.
- The current market capitalisation of Alembic Pharmaceuticals Ltd is approximately ₹16,715 crore.
- The P/E (Price-to-Earnings) ratio of Alembic Pharmaceuticals Ltd is 21.92. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Alembic Pharmaceuticals Ltd is 2.58. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Alembic Pharmaceuticals Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for APLLTD on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Alembic Pharmaceuticals Ltd has delivered a return of approximately 11.06%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Alembic Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 69.87% promoters, -4.56% FIIs, 15.94% DIIs, and 6.97% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
